The incidence of ductal carcinoma in situ (DCIS) has increased because of increasing use of sensitive imaging modalities. MRI is commonly used for the detection of breast cancer but has not yet been validated in randomized trials. There have not been randomized trials addressing optimal margins of excision or axillary sampling. Whole breast radiation after lumpectomy decreases the risk of recurrence but may be omitted in selected patients. Adjuvant Tamoxifen reduces the risk of recurrence but has no impact on overall survival rates.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/jso.22020 | DOI Listing |
Publication Analysis
Top Keywords
ductal carcinoma
8
carcinoma situ
8
situ dcis
8
randomized trials
8
risk recurrence
8
dcis breast
4
breast perspectives
4
perspectives biology
4
biology controversies
4
controversies current
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!